The increasing stress of modern life is a growing concern to researchers studying cognitive decline.
Read More ›
Four projects promoting the fight against cancer at UT Health San Antonio received a multimillion dollar boost.
A new tool is urgently needed to find a better treatment for pancreatic cancer. One researcher believes he has found one that provides a truer picture of the disease and how it affects humans.
A landmark study of DNA from people around the world identified new genetic risk factors for stroke. It is the largest genetic study of stroke to date, and could lead to stroke drug development and dementia treatment.
When an FDA advisory committee approved the first cannabidiol medicine for prescription use in epilepsy, it based its decision on recommendations of a UT Health San Antonio researcher.
Exposing the gut to chlamydia protects against subsequent infection in the genital tract and other tissues, researchers have discovered.
Scientists at UT Health San Antonio and UTHealth in Houston were awarded millions in grants to expand studies of a therapeutic antibody to stem the spread of breast cancer to the bone.
UT Health San Antonio has garnered highly competitive National Institutes of Health grants to speed the translation of research discovery into improved patient care.
The Max and Minnie Tomerlin Voelcker Fund has awarded $1.45 million to support three innovative research projects and one pilot research project.
The Cancer Prevention & Research Institute of Texas awarded $6 million to UT Health San Antonio to support the recruitment of an internationally known biochemist.